Literature DB >> 27217864

Author reply: The neutrophil-to-lymphocyte ratio in clinical practice.

Mehmet Ilker Gokce1, Nurullah Hamidi1, Evren Suer1, Semih Tangal2, Adil Huseynov1, Arif Ibiş1.   

Abstract

Year:  2016        PMID： 27217864      PMCID： PMC4839998          DOI： 10.5489/cuaj.3630

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  9 in total

1.  The lymphocyte-monocyte ratio in clinical practice.

Authors:  Sevket Balta; Zafer Demırer; Mustafa Aparci; Ali Osman Yildirim; Cengiz Ozturk
Journal:  J Clin Pathol       Date:  2015-08-25       Impact factor: 3.411

2.  A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range.

Authors:  William J Catalona; Alan W Partin; Martin G Sanda; John T Wei; George G Klee; Chris H Bangma; Kevin M Slawin; Leonard S Marks; Stacy Loeb; Dennis L Broyles; Sanghyuk S Shin; Amabelle B Cruz; Daniel W Chan; Lori J Sokoll; William L Roberts; Ron H N van Schaik; Isaac A Mizrahi
Journal:  J Urol       Date:  2011-03-17       Impact factor: 7.450

Review 3.  Cancer immunoediting from immune surveillance to immune escape.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe
Journal:  Immunology       Date:  2007-03-26       Impact factor: 7.397

Review 4.  Biomarkers in prostate cancer surveillance and screening: past, present, and future.

Authors:  K Clint Cary; Mathew R Cooperberg
Journal:  Ther Adv Urol       Date:  2013-12

Review 5.  Prostate-specific antigen and prostate cancer: prediction, detection and monitoring.

Authors:  Hans Lilja; David Ulmert; Andrew J Vickers
Journal:  Nat Rev Cancer       Date:  2008-04       Impact factor: 60.716

6.  Evaluation of neutrophil-to-lymphocyte ratio prior to prostate biopsy to predict biopsy histology: Results of 1836 patients.

Authors:  Mehmet Ilker Gokce; Nurullah Hamidi; Evren Suer; Semih Tangal; Adil Huseynov; Arif Ibiş
Journal:  Can Urol Assoc J       Date:  2015-11-04       Impact factor: 1.862

7.  Neutrophil and Lymphocyte Counts as Clinical Markers for Stratifying Low-Risk Prostate Cancer.

Authors:  Young Suk Kwon; Christopher Sejong Han; Ji Woong Yu; Sinae Kim; Parth Modi; Rachel Davis; Ji Hae Park; Paul Lee; Yun-Sok Ha; Wun-Jae Kim; Isaac Yi Kim
Journal:  Clin Genitourin Cancer       Date:  2015-08-06       Impact factor: 2.872

8.  Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.

Authors:  R J van Soest; A J Templeton; F E Vera-Badillo; F Mercier; G Sonpavde; E Amir; B Tombal; M Rosenthal; M A Eisenberger; I F Tannock; R de Wit
Journal:  Ann Oncol       Date:  2014-12-15       Impact factor: 32.976

9.  Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy.

Authors:  Takashi Kawahara; Sachi Fukui; Kentaro Sakamaki; Yusuke Ito; Hiroki Ito; Naohito Kobayashi; Koji Izumi; Yumiko Yokomizo; Yasuhide Miyoshi; Kazuhide Makiyama; Noboru Nakaigawa; Takeharu Yamanaka; Masahiro Yao; Hiroshi Miyamoto; Hiroji Uemura
Journal:  Oncotarget       Date:  2015-10-13
  9 in total
  1 in total

1.  Inflammatory parameters as predictive factors for complicated appendicitis: A retrospective cohort study.

Authors:  Ana Matos Ribeiro; Inês Romero; Carlos Costa Pereira; Filomena Soares; Álvaro Gonçalves; Susana Costa; João Barros da Silva
Journal:  Ann Med Surg (Lond)       Date:  2022-01-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.